SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19
Caroline Hirsch(University of Cologne), Nina Kreuzberger(University of Cologne), Jakob J Malin(University of Cologne), Cynthia So‐Osman(Sanquin), Yun Soo Park(University of Cologne), Ina Monsef(University of Cologne), Vanessa Piechotta(Robert Koch Institute), Christoph D. Spinner(TUM Klinikum), Susanne Salomon(University of Cologne), Erica M. Wood(Monash Health), Miriam Stegemann(LRS Institute of Tuberculosis and Respiratory Diseases), Zoe McQuilten, Khai Li Chai(Monash University), Nicole Skoetz(Medical University of Vienna), Lise J Estcourt(NHS Blood and Transplant)
Cited by 41
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
|JAMA|2020|884
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
|The Lancet Infectious Diseases|2023|658
Patient Blood Management
|JAMA|2019|619